German healthcare group Merck KGaA is looking for acquisitions and collaborations with start-ups to grow its drugs business in the United States, a senior Merck official said. The drug and chemicals maker gets some 20 percent of pharmaceutical revenue from the United States, compared with an average of about 50 percent at most global pharma firms. “That’s where we want to be,” Stefan Oschmann, who heads up Merck’s pharmaceutical business, told reporters during a visit to the Merck Serono bio incubator near Tel Aviv on Tuesday.
Help employers find you! Check out all the jobs and post your resume.
